152 related articles for article (PubMed ID: 37343601)
1. Preparation of PEGylated uricase attached magnetic nanowires and application for uric acid oxidation.
Kilimci U; Uygun DA
J Biotechnol; 2023 Aug; 373():12-19. PubMed ID: 37343601
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and pharmacodynamics of intravenous PEGylated recombinant mammalian urate oxidase in patients with refractory gout.
Sundy JS; Ganson NJ; Kelly SJ; Scarlett EL; Rehrig CD; Huang W; Hershfield MS
Arthritis Rheum; 2007 Mar; 56(3):1021-8. PubMed ID: 17328081
[TBL] [Abstract][Full Text] [Related]
3. Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase.
Ganson NJ; Kelly SJ; Scarlett E; Sundy JS; Hershfield MS
Arthritis Res Ther; 2006; 8(1):R12. PubMed ID: 16356199
[TBL] [Abstract][Full Text] [Related]
4. Uricase formulated with polyethylene glycol (uricase-PEG 20): biochemical rationale and preclinical studies.
Bomalaski JS; Holtsberg FW; Ensor CM; Clark MA
J Rheumatol; 2002 Sep; 29(9):1942-9. PubMed ID: 12233890
[TBL] [Abstract][Full Text] [Related]
5. A Therapeutic Uricase with Reduced Immunogenicity Risk and Improved Development Properties.
Nyborg AC; Ward C; Zacco A; Chacko B; Grinberg L; Geoghegan JC; Bean R; Wendeler M; Bartnik F; O'Connor E; Gruia F; Iyer V; Feng H; Roy V; Berge M; Miner JN; Wilson DM; Zhou D; Nicholson S; Wilker C; Wu CY; Wilson S; Jermutus L; Wu H; Owen DA; Osbourn J; Coats S; Baca M
PLoS One; 2016; 11(12):e0167935. PubMed ID: 28002433
[TBL] [Abstract][Full Text] [Related]
6. Immobilized-enzyme nylon-tube reactor for routine determination of uric acid in serum.
Sundaram PV; Igloi MP; Wassermann R; Hinsch W
Clin Chem; 1978 Oct; 24(10):1813-7. PubMed ID: 699291
[TBL] [Abstract][Full Text] [Related]
7. Activity and stability of uricase from Lactobacillus plantarum immobilizated on natural zeolite for uric acid biosensor.
Iswantini D; Nurhidayat N; Trivadila ; Widiyatmoko O
Pak J Biol Sci; 2014 Jan; 17(2):277-81. PubMed ID: 24783814
[TBL] [Abstract][Full Text] [Related]
8. Diabetes insipidus in uricase-deficient mice: a model for evaluating therapy with poly(ethylene glycol)-modified uricase.
Kelly SJ; Delnomdedieu M; Oliverio MI; Williams LD; Saifer MGP; Sherman MR; Coffman TM; Johnson GA; Hershfield MS
J Am Soc Nephrol; 2001 May; 12(5):1001-1009. PubMed ID: 11316859
[TBL] [Abstract][Full Text] [Related]
9. Immobilization of uricase on protamine bound to glass beads and its application to determination of uric acid.
Nakamura N; Murayama K; Kinoshita T
Anal Biochem; 1986 Feb; 152(2):386-90. PubMed ID: 3963371
[TBL] [Abstract][Full Text] [Related]
10. An amperometric uric acid biosensor based on chitosan-carbon nanotubes electrospun nanofiber on silver nanoparticles.
Numnuam A; Thavarungkul P; Kanatharana P
Anal Bioanal Chem; 2014 Jun; 406(15):3763-72. PubMed ID: 24718436
[TBL] [Abstract][Full Text] [Related]
11. Discrete analysis of serum uric acid with immobilized uricase and peroxidase.
Bhargava AK; Lal H; Pundir CS
J Biochem Biophys Methods; 1999 May; 39(3):125-36. PubMed ID: 10392568
[TBL] [Abstract][Full Text] [Related]
12. Serum Urate, Uricase, and Blood Pressure Control in Gout.
Borghi C; Virdis A
Hypertension; 2019 Jul; 74(1):23-25. PubMed ID: 31079534
[No Abstract] [Full Text] [Related]
13. PEG-uricase in the management of treatment-resistant gout and hyperuricemia.
Sherman MR; Saifer MG; Perez-Ruiz F
Adv Drug Deliv Rev; 2008 Jan; 60(1):59-68. PubMed ID: 17826865
[TBL] [Abstract][Full Text] [Related]
14. Study on performance of mimic uricase and its application in enzyme-free analysis.
Liu D; Yang P; Wang F; Wang C; Chen L; Ye S; Dramou P; Chen J; He H
Anal Bioanal Chem; 2021 Nov; 413(26):6571-6580. PubMed ID: 34417645
[TBL] [Abstract][Full Text] [Related]
15. PEGylation enhancement of pH stability of uricase via inhibitive tetramer dissociation.
Tian H; Guo Y; Gao X; Yao W
J Pharm Pharmacol; 2013 Jan; 65(1):53-63. PubMed ID: 23215688
[TBL] [Abstract][Full Text] [Related]
16. Fabrication of dissolved O2 metric uric acid biosensor using uricase epoxy resin biocomposite membrane.
Arora J; Nandwani S; Bhambi M; Pundir CS
Anal Chim Acta; 2009 Aug; 647(2):195-201. PubMed ID: 19591705
[TBL] [Abstract][Full Text] [Related]
17. Rationalization design, soluble expression and PEG modification of highly active recombinant human-porcine uricase mutant protein.
Tong M; Wang S; Luan J; Xie Q; Wang L; Shen X; Xiong S
Int J Biol Macromol; 2024 Jun; 269(Pt 1):131989. PubMed ID: 38697425
[TBL] [Abstract][Full Text] [Related]
18. Pegloticase: a novel agent for treatment-refractory gout.
Shannon JA; Cole SW
Ann Pharmacother; 2012 Mar; 46(3):368-76. PubMed ID: 22395256
[TBL] [Abstract][Full Text] [Related]
19. Enzyme-entrapped mesoporous silica for treatment of uric acid disorders.
Muthukoori S; Narayanan N; Chandra MS; Sethuraman S; Krishnan UM
J Biomed Nanotechnol; 2013 May; 9(5):907-14. PubMed ID: 23802423
[TBL] [Abstract][Full Text] [Related]
20. Development of a novel anti-inflammatory recombinant uricase with extended half-life for gout therapy.
Zhang Z; Fu N; Li Q; Quan J
Biochem Biophys Res Commun; 2023 Jul; 666():115-121. PubMed ID: 37182286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
